Occlusive Retinal Vessels Associated With Intravitreal Aflibercept, 8.0 mg
Key Points
Retinal vessel occlusion was observed after intravitreal aflibercept injection in one patient.
The patient had a history of neovascular age-related macular degeneration which may have contributed to the event.
The occlusion highlights potential adverse effects associated with intravitreal aflibercept treatment.
Further investigation is needed to assess the risk of occlusive events in similar patients.
Abstract
This case report describes occlusion of the retinal vessels following intravitreal injection of aflibercept, 8.0 mg, in a woman with neovascular age-related macular degeneration.